Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Fish and Richardson
US Army
McKesson
Chinese Patent Office
Express Scripts
Cipla
Boehringer Ingelheim
Daiichi Sankyo
Harvard Business School

Generated: February 24, 2018

DrugPatentWatch Database Preview

PHRENILIN FORTE Drug Profile

« Back to Dashboard

Which patents cover Phrenilin Forte, and when can generic versions of Phrenilin Forte launch?

Phrenilin Forte is a drug marketed by Valeant and is included in one NDA.

The generic ingredient in PHRENILIN FORTE is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.

US Patents and Regulatory Information for PHRENILIN FORTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant PHRENILIN FORTE acetaminophen; butalbital CAPSULE;ORAL 088831-001 Jun 19, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Colorcon
Daiichi Sankyo
QuintilesIMS
Medtronic
Healthtrust
Chinese Patent Office
Queensland Health
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot